DaVita (DVA) Expected to Announce Earnings on Thursday

DaVita (NYSE:DVA) is projected to post its Q1 2025 quarterly earnings results before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $1.75 per share and revenue of $3.22 billion for the quarter. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, analysts expect DaVita to post $11 EPS for the current fiscal year and $13 EPS for the next fiscal year.

DaVita Price Performance

NYSE DVA opened at $141.45 on Wednesday. The business’s fifty day moving average is $146.13 and its two-hundred day moving average is $155.01. The stock has a market capitalization of $11.32 billion, a P/E ratio of 13.17, a P/E/G ratio of 1.07 and a beta of 1.04. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita has a 1 year low of $131.27 and a 1 year high of $179.60.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. StockNews.com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. Barclays boosted their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.